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The heparan sulfate proteoglycan (HSPGs) is a compo- 
nents of the extracellular matrix of skeletal muscle that is 
concentrated at the neuromuscular junction (NMJ). Recent 
studies have suggested that HSPG, together with its bound 
peptide growth factors, plays important roles in autocrine 
or paracrine types of regulation of cell growth and differ- 
entiation. Heparin-binding growth-associated molecule 
(HB-GAM; also known as pleiotrophin, or ~18) is a newly 
discovered HSPG-bound factor that is expressed at high 
levels in the developing CNS and PNS. In this study, we 
examined the role of this factor in NMJ development by 
examining its relationship to the formation of ACh receptor 
(AChR) clusters. Using an antibody against recombinant 
rat brain HB-GAM, we found that this protein is present 
prominently on the surface of cultured Xenopus myotomal 
muscle cells by immunocytochemistry. It is associated 
with HSPGs as evidenced by the fact that heparin and he- 
parinase treatment greatly diminished the antibody label- 
ing. HB-GAM is concentrated at preexisting AChR hot 
spots as well as at those induced by polystyrene beads. In 
addition, this molecule is also concentrated at AChR clus- 
ters induced by spinal cord neurons in nerve-muscle co- 
cultures. To assess its function in synaptic induction, we 
applied recombinant HB-GAM-coated beads to cultured 
muscle cells to effect its focal presentation. Over 70% of 
these beads induced the formation of AChR clusters as 
shown by fluorescent a-bungarotoxin labeling. Further- 
more, bath application of HB-GAM inhibited the nerve-in- 
duced formation of AChR clusters. Thus, HB-GAM is an 
endogenous muscle-derived factor that may be a compo- 
nent of the molecular mechanism in postsynaptic induc- 
tion. 
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Synaptic development at the neuromuscular junction (NMJ) is 
induced by the contact between the growth cone of the motor 
axon and the skeletal muscle cell. This contact presents a highly 
localized signal to both the nerve and the muscle to initiate the 
formation of pre- and postsynaptic specializations that are pre- 
cisely registered in space (Hall and Sanes, 1993). Clustering of 
nicotinic ACh receptors (AChRs) is the hallmark of vertebrate 
postsynaptic development. In response to innervation, AChRs 
are clustered discretely at the nerve-muscle (N-M) contact. This 
spatial restriction in AChR clustering necessitates a signaling 
system that has a limited diffusion radius. 
Previous studies have shown that the heparan-sulfate proteo- 
glycan (HSPG) is an important component of the extracellular 
matrix (ECM) of skeletal muscle (Anderson and Fambrough, 
1983; Anderson et al., 1984; Bayne et al., 1984; Anderson, 
1986; Swenarchuk et al., 1990). They are concentrated at the 
NMJ in viva and in vitro as well as at aneural ACh receptor 
(AChR) clusters (“hot spots”) in cultured muscle cells. Recent 
studies have demonstrated that this proteoglycan can harbor hep- 
arin-binding growth factors (HBGFs) at the cell surface (Risau 
and Ekblom, 1986; Rifkin and Moscatelli, 1989; Klagsbrun and 
Baird, 1991; Bernfield et al., 1992; Salmivirta et al., 1992; Hi- 
gashiyama et al., 1993). These factors can be released or pre- 
sented to their receptors during cell-cell interaction to signal cell 
growth or differentiation (Saksela and Rifkin, 1990; Brunner et 
al., 1991). An important feature of this class of molecules is that 
they are spatially restricted when bound to HSPG (Flaumenhaft 
et al., 1990). The role of HBGFs in NMJ development is sug- 
gested by our recent studies that local presentation of basic fi- 
broblast growth factor (bFGF), which binds to HSPG with high 
affinity, via latex beads stimulates the formation of AChR clus- 
ters in cultured Xenopus muscle cells (Peng et al., 1991a). How- 
ever, immunocytochemical study has not revealed an abundance 
of bFGF at the surface of Xenopus skeletal muscle cells, nor at 
the NMJ (Baker et al., 1992). In addition, the primary sequence 
of this factor lacks a classical signal peptide (Esch et al., 1985; 
Mignatti et al., 1992). Thus, it is not clear how this molecule 
can be externalized to effect synaptic induction. 
To further explore the role of HSPG and its associated mol- 
ecules in NMJ development, we examined the expression and 
function of a newly discovered HBGE the heparin-binding 
growth-associated molecule (HB-GAM; also known as pleiotro- 
phin, or ~18). As its name implies, it binds to heparin and HSPG 
with high affinity (Rauvala, 1989; Li et al., 1990; Merenmies 
and Rauvala, 1990; Hampton et al., 1992; Raulo et al., 1992). 
The cDNA for this factor encodes a protein with 136 amino 
acids with an N-terminal signal sequence. The amino acid se- 
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quence of this molecule is highly conserved across species. Two 
features of this sequence are particularly striking. First, it shows 
a high content of basic amino acids which are clustered at its 
N- and C-terminals. Second, it possesses 10 cysteines, all of 
which have been shown to form disulfide bonds. These features, 
as well as the overall sequence, are shared by members of a 
family of retinoid acid-induced heparin-binding factors, such as 
midkine (Kadomatsu et al., 1988; Matsubara et al., 1990; 
Kretschmer et al., 1991). Previous studies have shown the ex- 
pression of HB-GAM in a variety of tissues, including brain, 
skeletal muscle, and kidney, in a developmentally regulated 
manner (Rauvala, 1989; Li et al., 1990; Hampton et al., 1992). 
While its expression is downregulated in other tissues during 
development, it persists in the brain beyond neonatal stages 
(Rauvala, 1989; Li et al., 1990). In vitro assays have shown that 
it exhibits neurite-promoting activity when applied on the sub- 
stratum (Rauvala, 1989; Kuo et al., 1990; Kretschmer et al., 
1991; Hampton et al., 1992) and may also be a mitogen to cer- 
tain fibroblast cell lines (Li et al., 1990; Fang et al., 1992). 
In this study, we examined the distribution of HB-GAM in 
cultured muscle cells and its relationship to NMJ development. 
Here we report that HB-GAM is present prominently at the sur- 
face of cultured Xenopus myotomal muscle cells, where it is 
associated with HSPG. It becomes concentrated at AChR clus- 
ters induced by innervation as well as by other stimuli. Local 
presentation of this factor by beads induces the formation of 
AChR clusters in these muscle cells. On the other hand, bath 
application interferes with the nerve-induced AChR clustering. 
These data suggest that HB-GAM is an endogenous muscle- 
derived growth factor that may play an important role in the 
signal transduction process leading to postsynaptic differentia- 
tion at the developing NMJ. 
Materials and Methods 
Production of recombinant proteins and antibodies. Recombinant HB- 
GAM was produced with the aid of a baculovirus vector and the se- 
creted protein was purified to apparent homogeneity from the culture 
medium of the SF9 cells as described previously (Raulo et al., 1992). 
For comparison, amphoterin, another heparin-binding factor was also 
used in this study (Rauvala et al., 1988; Merenmies et al., 1991). Re- 
combinant amphoterin was also expressed in SF9 cells using a bacu- 
lovims vector and purified in a similar manner as HB-GAM (Parkkinen 
et al., 1993). Immune sera against the purified recombinant HB-GAM 
were produced in rabbits as described previously (Raulo et al., 1992). 
IgG was isolated from the immune sera using protein A-Sepharose 
(Pharmacia, Sweden) as recommended by the manufacturer. For affinity 
purification of the antibodies, 5 mg of recombinant HB-GAM was cou- 
pled to a 1 ml cynogen bromide-activated Sepharose 4B column (Phar 
macia, Sweden). Antibodies bound to the affinity column from the im- 
mune sera in the presence of 0.6 M NaCl were purified as described 
previously (Rauvala et al., 1988). 
Cell cultures. Muscle cells were isolated from Xenopus embryos ac- 
cording to a previously published method (Peng et al., 1991b). They 
were plated on 35 mm tissue culture dishes for Western blot experi- 
ments or on 12 mm coverglass circles for immunofluorescence experi- 
ments. The cultures were maintained in Steinberg’s solution [60 mu 
NaCl, 0.7 mrvr KCl, 0.4 mM Ca(NO,),, 0.8 mM MgSO,, 10 mM HEPES, 
pH 7.41 supplemented with 10% L-15 medium, 1% fetal bovine serum, 
and 100 kg/ml gentamycin at 22’C (Peng et al., 1991b). To study NMJs 
in culture, neural tubes from Xenopus embryos were separated from the 
myotomes after collagenase treatment (1 mg/ml for 30 min) and dis- 
sociated into single neurons in Ca 2+ Mgz+-free Steinberg’s solution. , 
They were then plated onto 34 d muscle cultures. A ratio of five neural 
tubes per muscle culture was found to be satisfactory in the establish- 
ment of easily identifiable nerve-muscle pairs. Functional NMJs can be 
observed within the first day of N-M coculture. 
Xenopus kidney epithelial cell line A6 (Rafferty, 1969) was obtained 
from Dr. Howard Fried (Department of Biochemistry, University of 
North Carolina at Chapel Hill) and from American Type Culture Col- 
lection (Rockville, MD). It was cultured in Waymouth’s culture medium 
with 10% fetal calf serum and karamycin/gentamycin at 22°C in tissue 
culture flasks. 
Western blots. Muscle and epithelial cultures were washed three times 
with phosphate-buffered saline (PBS) and then lysed by the addition of 
lysis buffer (25 mM Tris-HCl, pH 7.4, 50 mM NaCl, 0.5% Na-deoxy- 
cholate, 2% NP-40,0.2% SDS, 10 yg/ml aprotinin, 0.5 kg/ml leupeptin, 
0.7 pg/ml pepstatin, and 0.5 mM PMSF). Cells were scraped off from 
the dishes and briefly homogenized with a Btinkmann (Westbury, NY) 
PT-1200 Polytron-type homogenizer. The protein concentration of the 
lysate was determined with the Bio-Rad (Richmond, CA) method using 
a kit supplied by the company. Samples were prepared according to 
Laemmli (Laemmli, 1970) and were resolved on a 12% SDS-polyacryl- 
amide gel. Proteins were transferred to nitrocellulose membrane (Bio- 
Rad) with a semi-dry electrophoretic transfer device (Pharmacia-LKB, 
Piscataway, NJ). The membrane was treated with the blocking buffer 
[lo mM Tris, pH 8, 50 mM NaCl, 0.05% Tween-20, 2% BSA, and 1% 
cold fish gelatin (Sigma, St. Louis, MO)] for 1 hr and then incubated 
with antibody against HB-GAM at 2 pg/ml reconstituted in Tris buffer 
(same as the blocking buffer except for the omission of BSA) at room 
temperature. After washing with the Tris buffer, the membrane was 
incubated with HRP-conjugated secondary antibody (Sigma) and the 
protein bands were visualized with the enhanced chemiluminescence 
(ECL) method with a kit supplied by Du Pont (Boston, MA). 
Imrnunojuorescent labeling. Cultures were immunolabeled with an- 
tibody against HB-GAM in the living state. Cultures were incubated 
with antibodies reconstituted with culture medium to a concentration of 
50-66 nM for 45 min, rinsed and labeled with a FITC or rhodamine- 
conjugated goat anti-rabbit secondary antibody (Organon Teknika, Dur- 
ham, NC) for 30 min. The labeling was carried out either at room 
temperature or at 4°C. They were either observed alive or fixed with 
95% ethanol at -20°C followed by mounting in a polyvinyl alcohol 
based mounting medium which contained 5% n-propyl gallate as anti- 
fading agent (Giloh and Sedat, 1982). To visualize AChR clusters, mus- 
cle cultures were also double labeled with tetramethylrhodamine-con- 
jugated o-bungarotoxin (R-BTX) at a concentration of 0.3 pM for 30 
min. As a control, we labeled cultures with the secondary antibody 
alone without the primary antibody. These cultures were completely 
devoid of fluorescent staining. The competition between HB-GAM and 
bFGF in binding to HSPG was studied by treating cultures with recom- 
binant bFGF (Synergen, Boulder, CO) at a concentration of 1 p,g/ml 
for 30 min, followed by labeling with a mouse monoclonal antibody 
against this protein (Type I from UBI, Lake Placid, NY) and the rabbit 
polyclonal HB-GAM antibody to visualize these two proteins at the cell 
surface. 
A monoclonal antibody against heparan sulfate (HepSS-1 from Sei- 
kagaku) was used to detect the HSPG on the surface of muscle cells 
(Kure and Yoshie, 1986). It was used at 1:200 dilution to label live 
cultures. The staining pattern of this antibody was similar to that ob- 
tained through the use of mAb 2AC2, an anti-HSPG core protein an- 
tibody kindly provided by Dr. M. J. Anderson (University of Calgary). 
Heparin and heparinase treatment. Low molecular-weight heparin 
(Sigma, M.W. 4000-6000) was used to displace HB-GAM from the cell 
surface. Cultures were treated with heparin at a concentration of lOO- 
500 kg/ml for 1 hr, followed by immunolabeling. To remove the HSPG 
from the cell surface, we treated cultures at room temperature with 
heparinase (Type I from Sigma) at a concentration of 50 U/ml for 4 hr 
in culture medium for immunolabeling or in PBS for Western blot. This 
was followed by antibody labeling. For Western blot, the conditioned 
medium after heparinase treatment was collected and centrifuged at 
13,000 ‘pm. The supernatant was freeze dried and desalted with spin 
columns (Bio-Rad) and prepared for PAGE and Western blots. After 
the heparinase treatment, the cells were also harvested by scraping them 
off the substrate, pelleted by centrifugation, washed and lysed with lysis 
buffer, and prepared for PAGE. 
Induction of AChR clustering by beads coated with HB-GAM. Ten 
micrometer polystyrene latex beads (Polysciences) were washed with 
95% ethanol, rinsed, and incubated with recombinant HB-GAM in the 
range of l-100 p,g/ml in PBS for l-3 hr. The beads were then washed 
with PBS and the unoccupied area on the bead surface was blocked 
with culture medium containing 1% fetal bovine serum or with PBS 
containing 1 mg/ml BSA. The beads were then applied to muscle cul- 
tures. Affer an-overnight incubation, the cultures were labeled with 
R-BTX or HB-GAM antibody. To visualize the adsorption of HB-GAM 
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on beads, we labeled the beads with anti-HB-GAM antibody followed 
by fluorescently conjugated secondary antibody. The size of bead-in- 
duced clusters was quantified by digital video imaging methods. The 
images were acquired with a SIT camera connected to a computer run- 
ning IMAGE-~ image processing software (Universal Imaging, Chester, 
PA). The clusters were then individually quantified with the analysis 
program in the same software package. 
Surumin and tyrphostin upplicatiolz. Suramin was obtained from FBA 
Pharmaceuticals (New York, NY). Cultures were treated with this drug 
at a concentration ranging from l-100 pM for 15 min before the ad- 
dition of HB-GAM-coated beads. The drug concentration was main- 
tained through the duration of the 24 hr bead-muscle coculture. Tyr- 
uhostins, RG-50864 (active) and RG-50862 (inactive). were kind gifts 
bf Rho&Poulenc Rdrer Central Research (Horshami’PA). They were 
dissolved in dimethyl sulfoxide (DMSO) to make a 40 mu stock that 
was stored at -80°C. Cultures were pretreated with tyrphostin in the 
range of 20-100 pM for 3 hr before the beads were added. Thereafter, 
they were maintained in the tyrphostin-containing medium for 24-48 
hr before R-BTX labeling. 
Bath application of HB-GAM and amphoterin. Stock solution of re- 
combinant HB-GAM or amphoterin was dialyzed against Steinberg so- 
lution through a membrane with 3000 M.W. cutoff. The dialyzed so- 
lution was then diluted with culture medium. To each muscle culture 
on 12 mm round coverglass circle placed in an 8 well dish whose 
bottom was lined with parafilm, 50 pl of medium with HB-GAM or 
amphoterin was added. Neurons, suspended in minimum amount of 
medium after dissociation, were seeded into each culture. The 8 well 
dish was then sealed, placed in a moisture chamber and incubated at 
22°C for 18-24 hr. The cultures were then labeled with R-BTX and 
examined live under a fluorescence microscope. The presence of AChR 
clusters along each unambiguous N-M contact visualized with phase- 
contrast optics was scored. The percentage of contacts that were positive 
in AChR clusters was calculated for each sample. 
Immunojluorescent labeling of embryos. The dorsal parts of embryos 
at stage 22-32, containing the myotomes, the neural tube and the no- 
tochord, were excised. They were briefly treated with Ca*+, Mg*+-free 
Steinberg’s solution to remove the skin. The pieces were then labeled 
in the living state with HB-GAM antibody followed by rhodamine- 
conjugated secondary antibody. In some experiments, pieces were dou- 
ble labeled with FITC-conjugated or-bungarotoxin. The embryo pieces, 
either in the living state or after fixation with 95% ethanol at -20°C 
were then mounted by sandwiching them between a slide and a cov- 
erslip, which caused their flattening. This made the myotomes clearly 
visible by their characteristic segmented appearance. The edge of the 
coverslip was sealed with nail enamel, and the specimen was observed 
under a fluorescence microscope. 
Results 
Immunoblot analysis of HB-GAM in Xenopus cells 
To examine the presence of HB-GAM in Xenopus muscle cells, 
we first conducted Western blot analyses on these cells. As 
shown in Figure 1 (lane l), the polyclonal antibody made against 
baculovirus-derived recombinant HB-GAM recognized the re- 
combinant protein as a major 18 kDa band. The minor band at 
a slightly lower molecular mass in this lane is probably a pro- 
teolytic breakdown product. In contrast, the same amount of 
recombinant bFGE which also has a molecular mass of 18 kDa, 
was not recognized by this antibody (Fig. 1, lane 2). When the 
lysate of cultured Xenopus muscle cells was electrophoresed, 
blotted, and probed with this antibody, a band at 18 kDa was 
clearly seen (Fig. 1, lane 4). In this and other muscle samples, 
a nonspecific band at 100 kDa was also observed. This band is 
due to the yolk protein that is present in large amount inside 
these cells in the form of yolk platelets. Since the yolk protein 
is very sticky, it tends to adsorb antibodies in a nonspecific 
manner, resulting in nonspecific bands in Western blots (Evans 
and Kay, 1991). A previous study has shown that HB-GAM is 
also found in embryonic rat kidney (Merenmies and Rauvala, 
1990). Thus, we also studied the expression of this protein in 







Figure I. Western blot of HB-GAM. Lane I, Recombinant HB-GAM, 
0.25 pg; lane 2, recombinant bFGE 0.25 kg; lane 3, A6 cell lysate; 
lane 4, muscle cell lysate; lane 5, conditioned medium from A6 cultures 
after heparinase treatment; lane 6, A6 cell lysate after heparinase treat- 
ment; lane 7, conditioned medium from muscle cultures after heparinase 
treatment; lane 8, muscle cell lysate after heparinase treatment. In lanes 
I, 3, 4, 7, a band at 18 kDa (p18) corresponding to HB-GAM can be 
seen. The 100 kDa band seen in lanes 4 and 8 is due to yolk protein 
in these muscle cells, which is very sticky and tends to give nonspecific 
antibody binding. The 30 kDa minor band in lanes 3 and 5 is routinely 
seen in the A6 preparation. Since it is eluted from the cell surface after 
heparinase treatment (lane 5) and is no longer seen in the cell lysate 
(lane 6), this protein is probably also bound to the HSPG. It may rep- 
resent another protein that shares structural homology with HB-GAM. 
The broadening of the bands in lane 5 is due to protein overloading. 
Affinity-purified HB-GAM antibody was used in this experiment. 
(Rafferty, 1969) as a way to further confirm the specificity of 
the antibody to the Xenopus protein. As shown in Figure 1 (lane 
3), the A6 cell lysate also exhibited a prominent band at 18 kDa 
when the Western blot was probed with the anti-HB-GAM an- 
tibody. 
Since HB-GAM is a heparin-binding molecule, it may be 
bound to the HSPG at the cell surface. To test this, we treated 
cultures with heparinase, collected and concentrated the condi- 
tioned medium, and probed it with the HB-GAM antibody. We 
found that most of the HB-GAM was released into the medium 
in both A6 (Fig. 1, lane 5) and muscle (Fig. 1, lane 7) cultures 
by heparinase. Only a small amount of this protein was left on 
cells after enzymatic treatment (Fig. 1, lane 6 for A6 and lane 
8 for muscle). These studies suggest that the bulk of HB-GAM 
is present on the cell surface in a heparinase-sensitive manner. 
Immunolocalization of HB-GAM 
Immunofluorescence studies were conducted on live cultures to 
determine the cellular localization of this molecule. As shown 
in Figure 2, A and B, HB-GAM antibody labeled the cell surface 
in a punctate, streaky or filamentous pattern in noninnervated 
muscle cells. The confocal image in Figure 2A shows that the 
entire cell surface was labeled. Most, but not all, of the labeling 
was removed by treating cells with heparinase (Fig. 2B) or with 
3030 Peng et al. * The Role of HB-GAM In Synaptogenesis 
Figure 2. Confocal stereo image pairs 
of HB-GAM distribution on the surface 
of muscle cells before (A) and after (B) 
heparinase treatment. HB-GAM is 
present on the entire cell surface. He- 
parinase removes a significant amount 
of this protein from the cell surface. 
The m-r&heads in B point to residual 
HB-GAM staining after the enzvmatic 
treatment. The l&ger fluoresce& ob- 
jects around the cell periphery are au- 
tofluorescent yolk granules released 
from damaged cells during dissocia- 
tion. 
heparin (data not shown). Heparinase partially removes heparan- 
sulfate glycosaminoglycan (GAG) side chains from the core pro- 
tein of HSPG, whereas heparin presumably solubilizes factors 
that are bound to HSPG at the cell surface. These results thus 
indicate that HB-GAM is associated with HSPG at the surface 
of Xenopus muscle cells, in consistency with Western blot data 
presented above. A punctate labeling pattern of HB-GAM was 
also observed on the surface of A6 cells and heparinase also 
abolished the bulk of the labeling on these cells (data not 
shown). In addition to the diffusely distributed pattern, patches 
of the cell surface where HB-GAM was concentrated were also 
observed (Figs. 3B,D; 4B,D,F). These HB-GAM hot spots were, 
in fact, often colocalized with AChR clusters (Fig. 4) as de- 
scribed below. No difference in the appearance of HB-GAM 
labeling at 20°C versus 4°C was observed. This rules out the 
possibility that the labeling pattern is due to a redistribution of 
the antigen. 
To demonstrate further the association of HB-CAM with 
HSPG, we double-labeled muscle cells with the rabbit polyclon- 
al HB-GAM antibody and a mouse monoclonal antibody against 
heparan sulfate (mAb HepSS-1). The patterns of HB-GAM and 
HSPG hot spots were then compared. As shown in Figure 3, A 
and B, and C and D, a good colocalization of these two mole- 
cules was often observed at these patches. However, this is not 
a constant feature as some of the HSPG patches were clearly 
under populated by HB-GAM as shown in Figure 3, E and F. 
This suggests that HB-GAM only occupies a fraction of the 
available binding sites on the GAG chains of the HSPG mole- 
cules. By double labeling muscle cells with mAb HepSS-1 and 
a rabbit polyclonal antibody against perlecan (kindly provided 
by Dr. J. R. Hassell, University of Pittsburgh), the major base- 
ment-membrane HSPG (Noonan et al., 1991), we recently found 
that the HSPG that HB-GAM binds to is indeed perlecan (D.ED. 
and H.B.P., unpublished results). 
In our previous study, we showed that exogenously applied 
bFGF binds to HSPG at the surface of Xenopus muscle cells 
(Baker et al., 1992). To determine whether the site on HSPG 
occupied by HB-GAM is also recognized by bFGF, we incubated 
cells with a 1 kg/ml solution of bFGF for 30 min and then 
doubly labeled them with the HB-CAM antibody and a mouse 
monoclonal antibody against bFGE Our results showed that the 
application of exogenous bFGF nearly abolished HB-CAM 
staining (Fig. 3G,H). This observation shows that exogenous 
bFGF was able to displace the endogenous HB-GAM from its 
binding sites on the HSPG. To determine whether this displace- 
ment was simply due to the basic nature of bFGF, we also ex- 
amined the effect of another heparin-binding protein amphoterin 
(p30), which is highly basic in its N-terminal amino-acid com- 
position (Merenmies et al., 1991), and two polycations, poly- 
ornithine and polylysine. We found that amphoterin at 1 pg/ml 
was much less effective and polyornithine and polylysine at sim- 
ilar concentration were ineffective in displacing HB-GAM. 
Thus, bFGF and HB-GAM may compete specifically for the 
same GAG sequences of HSPG. 
Colocalization of HB-GAM with AChR clusters and the NMJ 
To understand whether HB-GAM is involved in the formation 
of AChR clusters in cultured muscle cells, we compared the 
localization of these two molecules at sites where they were 
concentrated. Double labeling cultures with R-BTX and HB- 
GAM and FITC-conjugated secondary antibody showed a gen- 
eral colocalization of HB-GAM antibody and AChR hot spots 
in uninnervated muscle cells (Fig. 4A-D). However, when ex- 
amined at high magnification as in Figure 4A-D, it became clear 
that these two types of specializations were not identical despite 
their colocalization. The HB-GAM clusters were in general 
slightly larger than the AChR clusters (Fig. 4C,D). Quantitation 
of this relationship showed that 61% of AChR hot spots were 
substantially overlapped by HB-GAM (as shown in Fig. 4A-D), 
3 1% of them showed partial overlap and 8% were not correlated 
with HB-GAM at all (n = 144). We also examined the relation- 
ship between these two molecules at bead-induced AChR clus- 
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Figure 3. A-F, Correlation between HSPG and HB-GAM in muscle 
cells. Cultures were double labeled with a heparan-sulfate antibody (A, 
C, E) and HB-GAM antibody (B, D, F). The top two examples (A-B 
and C-D) show good spatial correlation of HSPG and HB-GAM hot 
spots. In the third example (E-F), only a small amount of HB-GAM is 
associated with this HSPG hot spot. (e--H) Applying recombinant bFGF 
(1 u&ml for 30 min) to the cells resulted in bright bFGF labeling 
(&e&k in G) at the expense of HB-GAM (H). Th& shows that bFGF 
can compete with HB-GAM for binding sites on HSPG. 
ters. In this study, uncoated polystyrene beads were used to in- 
duce receptor clustering according to previous methods (Baker 
et al., 1992). As shown in Figure 4, E and F, HB-GAM was 
also concentrated at bead-induced AChR clusters, although there 
was a discrepancy both in morphology and in size. 
To study the influence of innervation on HB-GAM distribu- 
tion, we cocultured muscle cells with neurons dissociated from 
neural tubes of Xenopus embryos. R-BTX labeling revealed the 
formation of NMJ at 50%-90% of the nerve-muscle contacts as 
evidenced by the clustering of AChRs. Double labeling with 
both R-BTX and HB-GAM antibody showed that this molecule 
was concentrated at AChR clusters at the NMJ. Two examples 
of this colocalization are shown in Figure 5. These nerve-in- 
duced AChR clusters were generally associated with a relatively 
precise colocalization of HB-GAM. Thus, innervation induces 
both AChRs and HB-GAM to cluster at the nerve-muscle con- 
tact. It should be noted, however, that the HB-GAM was still 
present diffusely at extrasynaptic membrane even after inner- 
vation (Fig. 5&E). Labeling live, cultured Xenopus spinal cord 
neurons not in contact with muscle cells showed no HB-GAM 
at their surface (H.B.P., unpublished results). 
HB-GAM was also detected at AChR clusters in C2C12 my- 
otubes by immunostaining with the anti-recombinant HB-GAM 
antibody and with an affinity-purified anti-HB-GAM peptide an- 
tibody that binds to the rodent sequence (Rauvala, 1989), where- 
as polyclonal antibodies to the mouse midkine protein did not 
stain these myotubes (data not shown). This indicates that the 
immunostaining of AChR clusters by the HB-GAM antibodies 
is not due to midkine, another member of this protein family. 
Thus, the colocalization of HB-GAM with AChR clusters is a 
conserved phenomenon from Xenopus to mouse. 
Induction of AChR clustering by local presentation of HB- 
GAM via beads 
To examine whether HB-GAM can function as an inducer for 
postsynaptic development in skeletal muscle, we locally applied 
this molecule to cultured Xenopus muscle cells via beads. Poly- 
styrene 10 pm latex beads were coated with recombinant rat 
HB-GAM by incubating them in a solution containing HB-GAM 
at a concentration of 100 pg/ml for several hours. Beads coated 
with HB-GAM showed intense fluorescence after labeling with 
HB-GAM antibody and fluorescent secondary antibody, indi- 
cating the adsorption of HB-GAM to the beads. Control beads 
coated with bovine serum albumin (BSA), fetal bovine serum, 
or other factors, such as EGF, NGE and PDGE were not labeled 
by the antibody (data not shown). These beads were then applied 
to muscle cultures. After an incubation period ranging from 6 
to 24 hr, the cultures were labeled with R-BTX. As shown in 
Figure 6, a high percentage (between 60% and 90%) of bead- 
muscle contacts were associated with AChR clusters. These 
clusters were discretely localized to the contact area. In contrast, 
control beads coated with BSA, serum proteins, EGE PDGE 
NGE immunoglobulins, laminin, or tenascin were ineffective in 
inducing AChR clustering even though they also adhered to the 
cells (Peng et al., 1991a). The efficacy of the beads in inducing 
AChR clustering depends on the surface HB-GAM concentra- 
tion. Beads incubated in a solution containing 10 pg/ml or less 
of HB-GAM were ineffective in inducing AChR clustering and 
there was an abrupt increase in the cellular response at 25 kg/ml 
incubation concentration. 
In addition to inducing AChR clustering at sites of contact, 
these HB-GAM-coated beads were also effective in causing a 
dispersal of preexisting AChR hot spots at sites away from the 
beads (data not shown). Thus, these beads can mimic two effects 
of nerve innervation on the skeletal muscle: the local induction 
of AChR clustering at nerve-muscle contacts and the global 
dispersal of AChR hot spots at extrasynaptic sites. 
The role of tyrosine kinase activation in the bead-induced 
AChR clustering 
To test whether the effect of HB-CAM in inducing AChR clus- 
tering is mediated by a cell surface receptor, we studied the 
effect of suramin on the bead-induced AChR clustering. Suramin 
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Figure 4. Association of HB-GAM 
with AChR clusters. A, C, E, R-BTX 
labeling; B, D, F, HB-GAM labeling. 
HB-GAM is closelv associated with 
preexisting AChR got spots (left col- 
umn) or bead-induced clusters (right 
column, arrowheads), although they 
are not congruent in their fine patterns. 
is a small (MW 1500), polyanionic molecule that has been wide- 
ly used to interfere with the ligand-receptor interaction involved 
in peptide growth factor signaling (Betsholtz et al., 1986; Coffey 
et al., 1987; Huang and Huang, 1988; Fleming et al., 1989; 
Behrendt et al., 1993). At a concentration of 100 pM, suramin 
reduced the percentage of HB-GAM bead-muscle contacts that 
were positive in AChR clusters to 30% of the control value. The 
clusters that did form in the presence of suramin were much 
smaller in size. The median cluster size was about 10.3 pm2 in 
the control (n = 100) and was reduced to 2.7 pm2 in 50 PM 
suramin (n = 100). 
Although the receptor for HB-GAM has not been elucidated, 
we suspected that the activation of a tyrosine kinase-mediated 
signaling pathway may be involved in the induction of AChR 
clustering by this molecule as suggested by previous studies (Qu 
et al., 1990; Wallace et al., 1991; Baker and Peng, 1993). This 
was tested by the use of the tyrosine kinase inhibitor tyrphostin 
RG-50864 (Lyall et al., 1989; Levitzki and Gilon, 1991; Seckl 
and Rozengurt, 1993). As shown in Figure 7, the efficacy of 
beads in inducing AChR clustering was blocked by this com- 
pound with a half-inhibitory concentration of 50 pM. Cells re- 
main viable at these concentrations of tyrphostin as shown in 
previous studies (Peng et al., 1991a; Baker and Peng, 1993). In 
addition to blocking the formation of AChR clusters, tyrphostin 
also abolished the effect of beads in causing the dispersal of 
preexisting AChR hot spots (data not shown). Thus, this tyrosine 
kinase inhibitor reversed both the local, cluster-inducing and the 
global, cluster-dispersing effects of the beads. An inactive form 
of tyrphostin, RG-50862, was used as a control in these studies 
and was found to have no effect on bead-induced AChR clus- 
tering. 
Effect of bath HB-GAM application on NMJ formation 
To further understand the role of HB-GAM in NMJ formation, 
we investigated the effect of interfering with the local HB-GAM 
signaling in the formation of AChR clusters induced by N-M 
contact. Since a good neutralizing antibody against HB-GAM 
had not been generated, we tested the effect of exogenous HB- 
GAM in AChR clustering. Muscle cultures were treated with 
recombinant HB-GAM and then seeded with spinal cord neu- 
rons. After an 18-24 hr coculture period, the cultures were la- 
beled with R-BTX and AChR clustering at N-M contacts was 
assessed. The percentage of contacts that exhibited AChR clus- 
tering was determined by scoring all of the clearly identifiable 
contacts in each culture. In control cultures not treated with HB- 
GAM, more than 90% of contacts exhibited AChR clustering in 
this series of experiments. HB-GAM at a concentration of 25- 
50 p,g/ml (1.4-2.8 pM) significantly suppressed the nerve-in- 
duced clustering process and essentially abolished it at 75-100 
pg/ml (4.2-5.6 FM) (Fig. 8). An example of this suppression is 
shown in Figure 9 (compare A with B and C). Clusters that did 
develop at these high HB-GAM concentrations appeared to be 
more diffuse and less intense than the control ones (Fig. 90). 
Bath application of HB-GAM, however, did not result in an 
increase in the formation of AChR clusters in extrasynaptic area 
of nerve-contacted muscle cells or in noninnervated muscle 
cells. Nor did we observe a decrease in the number of AChR 
hot spots at these concentrations. This suggests that the bath- 
Figure 5. Association of HB-GAM with the NMJ in culture. The lef 
and right columns are two different examples. A, D, R-BTX labeling; 
B, E, HB-GAM labeling; C, F, phase contrast. HB-GAM is concentrated 
at nerve-induced AChR clusters (arrowheads), although it is also pres- 
ent in extrajunctional areas (B, E). The bright object at the lower right- 
hand side of E is a fluorescent cell debris. 
applied HB-GAM did not cause deleterious effect on the muscle 
cell. When the HB-GAM concentration was raised to 200 Fg/ml, 
hot spots were indeed dispersed over a 24 hr period. The cells 
remained viable even at this concentration. 
To determine the specificity of the HB-GAM inhibition in 
nerve-induced AChR clustering, we also treated cultures with 
amphoterin (Atn), another heparin-binding protein that contains 
approximately the same proportion (28%) of cationic, mainly 
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Figure 6. Induction of AChR clustering by HB-GAM-coated beads. 
R-BTX labeling (A) revealed the high efficacy of these beads in induc- 
ing this specialization: only 2 out of a total of 15 bead-muscle contacts 
(B, asterisks) failed to induce clusters. 
lysine, residues as in HB-GAM (Merenmies et al., 1991). As 
shown in Figures 8 and 9, E and F, this protein had no effect 
on nerve-induced AChR clustering at concentrations as high as 
100 (*g/ml. 
0 10 20 30 40 50 60 70 80 90 100 
Tyrphostin concentration, PM 
Figure 7. Inhibition of AChR clustering induced by HB-GAM-coated 
beads by the tyrosine kinase inhibitor tyrphostin RG50864. 
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Figure 8. Effect of bath HB-GAM application on NMJ formation. The 
percentage of N-M contacts with AChR clustering was calculated from 
each N-M coculture and is expressed as a relative value to the control 
culture. The value for each concentration is the mean of several exper- 
iments. The number of experiments for each concentration is indicated 
in the parentheses. The error bars are SEs. HB-GAM, at concentrations 
above 25 p&ml, significantly suppressed AChR clustering induced by 
the nerve. In contrast, another heparin-binding protein amphoterin (Am) 
was ineffective. 
Distribution of HB-GAM in vivo 
To begin to understand the role of HB-GAM in vivo, we con- 
ducted preliminary experiments to examine its distribution in 
Xenopus embryos. Dorsal embryo pieces were labeled with HB- 
GAM antibody followed by fluorescent secondary antibody in 
living state without fixation, similar to the method used in la- 
beling cell cultures described above. As shown in Figure 10, A 
and C (arrowheads), HB-GAM labeling was observed within the 
space between adjacent myotomes in embryos at stage 22-24. 
This intermyotomal area, filled with various ECM molecules, is 
traversed by processes from motoneurons to establish NMJs at 
the ends of the myotomal muscle fibers which abut this space. 
However, at this early stage, NMJs had not formed as shown by 
the absence of AChR clusters (Fig. 10B). When older embryos 
(after stage 30) were examined, more prominent HB-GAM la- 
beling was detected in this region (Fig. 1OD). At these later 
stages, the HB-GAM localization was comparable to the sites of 
NMJs as shown by the location of AChR clusters (Fig. 10E). 
These data suggest that HB-GAM is first concentrated at future 
sites of NMJ formation prior to the arrival of the nerve and later 
becomes colocalized with the junctions. HB-GAM was absent 
from the notochord with the live-labeling method employed in 
this study. 
Discussion 
In this study, we have shown that HB-GAM is an endogenous 
muscle-derived factor normally stored on the HSPG at the sur- 
face of Xenopus muscle cells. Despite its concentration at AChR 
hot spots, this molecule is generally distributed in a diffuse man- 
ner on the cell surface in a pattern analogous to the HSPG dis- 
tribution. Innervation results in concentration of HB-GAM at the 
NMJ. The induction of AChR clustering by HB-GAM-coated 
beads suggests a role for this molecule in signaling postsynaptic 
development. The activation of a tyrosine kinase-mediated path- 
way is probably involved in the signal transduction process ac- 
tivated by HB-GAM, since it is blocked by an inhibitor to ty- 
rosine kinase. In addition, bath application of HB-GAM 
antagonizes the nerve-induced AChR clustering process. To our 
knowledge, this is the first demonstration of an endogenous pep- 
tide growth factor that colocalizes with a synapse and can act 
as its inducer. 
Previous works have demonstrated two other roles for HB- 
GAM. This molecule has been shown to be a neurite-promoting 
and guidance factor when it is bound to the substratum (Rauvala, 
1989; Kuo et al., 1990; Li et al., 1990; Hampton et al., 1992; 
Raulo et al., 1992; Rauvala et al., 1994). In fact, neurons in the 
CNS are rich sources for HB-GAM (Rauvala et al., 1994). Im- 
munocytochemical studies using fixed and permeabilized neu- 
rons have shown its presence in the soma and the neurite (Rau- 
vala, 1989). Its absence from the surface of live neurites as 
shown in this study may be correlated with the lack of an ex- 
tensive HSPG-containing ECM at the neuronal surface. HB- 
GAM may also be a mitogen for certain cell lines (Li et al., 
1990; Fang et al., 1992) although this effect is controversial 
(Merenmies, 1992; Raulo et al., 1992). This molecule shares 
high amino acid homology with two other heparin-binding fac- 
tors, midkine (Matsubara et al., 1990; Muramatsu et al., 1993) 
and retinoic acid-inducible heparin-binding factor, which may 
be the avian homolog of midkine (Vigny et al., 1989; Cockshutt 
et al., 1993). Thus, HB-GAM is a member of an emerging fam- 
ily of new HBGFs which may play regulatory roles in devel- 
opment. 
Although the receptor for HB-GAM has not yet been eluci- 
dated, a recent study showed that this factor can be crosslinked 
to 127 and 155 kDa cell surface proteins on NIH 3T3 cells (Kuo 
et al., 1992) and can stimulate tyrosine phosphorylation of a 200 
kDa protein in two fibroblast cell lines (Li and Deuel, 1993). 
Thus, a kinase-dependent signaling pathway is likely involved 
in the interaction of HB-GAM with cells. This is also supported 
by our current result that a tyrosine kinase inhibitor blocks 
AChR clustering induced by HB-GAM beads. 
The role of HSPG and its associated factors in synaptogenesis 
HSPGs are ubiquitous components of the ECM in a variety of 
cell types, including skeletal muscle and neurons (Ruoslahti, 
1989; Bernfield et al., 1992; Yanagishita and Hascall, 1992; 
Halfter, 1993). Recent studies have elucidated two roles for this 
class of molecules. First, they serve as storage sites for HBGFs, 
such as bFGE heparin-binding EGE and HB-GAM (Rauvala, 
1989; Rifkin and Moscatelli, 1989; Higashiyama et al., 1992). 
This provides a mechanism for localizing these factors to the 
cell surface, a strategic location for intercellular signaling. In 
addition, a second role for HSPG as an active participant in the 
signaling process has recently been elucidated (Klagsbrun and 
Baird, 1991; Ruoslahti and Yamaguchi, 1991). As shown in the 
case of bFGF receptor, the formation of a ternary complex, in- 
volving the receptor, bFGF and HSPG, is essential for cell stim- 
ulation (Rapraeger et al., 1991; Yayon et al., 1991; Kan et al., 
1993). Whether this paradigm also applies to the action of HB- 
GAM awaits further studies. 
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In the case of NMJ development, the involvement of HSPG 
in the induction of AChR clustering is suggested by several lines 
of evidence. First, HSPG is concentrated at the NMJ both in 
vivo and in vitro and is coclustered with AChRs during inner- 
vation of cultured muscle cells (Anderson and Fambrough, 1983; 
Anderson et al., 1984; Bayne et al., 1984). This property is also 
shared by HB-GAM as shown in this study. Second, culturing 
nerve and muscle cells in the presence of heparin and heparan 
sulfate, but not condroitin sulfate, suppresses the formation of 
AChR clustering induced by the nerve in culture (Hirano and 
Kidokoro, 1989; see also Baker et al., 1992). In genetic variants 
of the mouse C2 myotubes that are defective in GAG synthesis, 
either in its elongation or sulfation, spontaneous clustering of 
AChRs into hot spots fails to occur (Gordon and Hall, 1989; 
Figure 9. Effect of bath HB-GAM 
application on NMJ formation. A, 
NMJs in a control N-M coculture. The 
R-BTX labeling shows extensive clus- 
tering of AChRs (arrowheads) on two 
adjacent muscle cells innervated by a 
common nerve. B, C, In the presence 
of 50 pg/ml HB-GAM in the bath, the 
nerve-induced AChR clustering was 
substantially suppressed as shown in 
this example. The N-M contact shown 
in C (between arrowheads) was devoid 
of AChR clustering (B), although hot 
spots were present on this muscle cell. 
D, At higher HB-GAM concentration 
(75 yg/ml), the few remaining nerve- 
induced clusters showed a diffuse ap- 
pearance and were generally much 
dimmer than control ones as shown by 
R-BTX fluorescence. E, F, In contrast 
to HB-GAM, amphoterin at 100 pg/ml 
had no effect on AChR clustering in- 
duced by the nerve. 
Gordon et al., 1993). Recent studies have shown that heterokar- 
yons of these defective cells that have restored GAG synthesis 
exhibit normal AChR clustering (Jung et al., 1993). This further 
illustrates the necessity of HSPGs in AChR clustering. 
Our results suggest that the importance of HSPG in AChR 
clustering may lie in its association with HBGFs and HB-GAM 
is probably one such factor. The strong heparin-binding property 
of this class of proteins enables them to be localized in the ECM. 
When these molecules are bound to the HSPG, they exist in a 
kind of latent form. Upon cell-cell contact, these factors are 
locally presented to interacting cells and become active in sig- 
naling (Saksela and Rifkin, 1990). This presentation is presum- 
ably carried out by the nerve during innervation. The capability 
to present these molecules may be specific to the neuron, since 
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Figure 10. HB-GAM localization in 
the myotomes of the Xenopus embryo. 
A-C, Stage 24 embryo. HB-GAM was 
concentrated within the inter-myotomal 
region (arrowheads in A), which can be 
seen in bright field in C. At this stage, 
NMJs had not formed as shown by the 
absence of fluorescent BTX labeling in 
this region (B). The myotomes (M) 
contained a lot of yolk which yielded 
autofluorescent background as shown 
in A and B. D-E, Stage 30-32 embry- 
os. The HB-GAM labeling (arrow- 
heads in D) can be seen more promi- 
nently in the intermyotomal region in 
these older embryos. This labeling pat- 
tern was comparable to the distrib;?ion 
of AChR clusters as shown by fluores- 
cent BTX labeling (arrowheads in E). 
AChR clustering does not occur at muscle-muscle contact in 
Xenopus cultures. The nature of the presentation mechanism is 
unknown. Previous studies suggest hat the release of proteases 
by the growth cone may modulate the HSPG at N-M contact to 
effect the presentation of its bound factors (Anderson, 1986; 
Seeds et al., 1992). Alternatively, the nerve may secrete specific 
molecules, such as neuronal HSPG (Halfter, 1993), that can 
competitively displace factors bound to the muscle HSPG to 
effect stimulation at the contact site. The stimulation probably 
involves the activation of a receptor tyrosine kinase by the lo- 
cally displaced HB-GAM as our inhibitor study shows. In any 
event, our study demonstrates that beads can effectively mimic 
the nerve in presenting these factors to the muscle cell to effect 
synaptic induction. On the other hand, bath application of ex- 
ogenous HB-GAM suppresses the cluster formation. This can be 
explained by the fact that muscle cells usually respond only to 
local signals presented by the nerve during synaptogenesis. 
When they are globally stimulated by exogenous ligand, the cell 
is most likely overwhelmed so that it can no longer discern the 
positional information provided by the nerve via its local pre- 
sentation of endogenous HB-GAM, thus resulting in failure to 
cluster AChRs. 
In agreement with the suggested role as a muscle-derived syn- 
aptogenic factor, HB-GAM is expressed in developing muscle 
in vivo. This was previously shown by Northern and Western 
blots (Li et al., 1990; Merenmies and Rauvala, 1990) and by in 
situ hybridization (Vanderwinden et al., 1992). Immunostaining 
of the rat limb buds shows that after the midgestation period (on 
embryonic days 15-17) HB-GAM is mainly found in desmin- 
positive muscle cells, in which it partially colocalizes with the 
AChR clusters (E. Szabat and H. Rauvala, unpublished results). 
The localization of this molecule at the intermyotomal junction 
where NMJs develop as revealed in this study is also consistent 
with its role in vivo. Significantly, the HB-HAM promoter con- 
tains several consensus (CANNTG) sequences for MyoD bind- 
ing (Li et al., 1992; Milner et al., 1992). This suggests that the 
expression of HB-GAM is linked to muscle differentiation, 
which is known to be controlled by transcription factors of the 
MyoD family. The presence of MyoD binding sites within the 
HB-GAM promoter suggests a coordinate expression of HB- 
GAM and AChR in muscle cells, since the expression of AChR 
subunits is also known to be controlled by MyoD-type transcrip- 
tion factors (Salpeter et al., 1992). 
Extensive studies have established the central role of agrin, 
an ECM-bound molecule enriched at the NMJ, in directing post- 
synaptic differentiation (McMahan et al., 1992; Cohen et al., 
1994; Bowe and Fallon, 1995). The results of this study suggest 
that agrin and HB-GAM may both be involved in postsynaptic 
induction. Whether these represent independent or overlapping 
pathways awaits further investigation. 
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